The National Reconstruction Fund has taken a $54 million stake in Synchron, the Melbourne-founded startup developing a non-invasive brain-computer interface that rivals Elon Musk’s Neuralink, as part of a $305 million Series D funding round.
Synchron, which relocated to the United States in 2021 after being unable to raise enough capital in Australia, will use the funding to conduct its final phase of clinical trials with the goal of securing …
Want to know how this story ends?
Become a subscriber for complete access to all stories on InnovationAus.com and our daily newsletter.
Already a member? Log in here
Do you know more? Contact James Riley via Email.